Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin for LV Thrombus after STEMI
NCT05705089Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Jul 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Left ventricular thrombosis (LVT), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Jul 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on NCT05705089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705089.